Cargando…

Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study

BACKGROUND: Polysaccharide pneumococcal vaccine is recommended for use in HIV-infected adults in Brazil but there is uncertainty about its effectiveness in this patient population. The main objective of this study was to assess the effectiveness of the 23-valent polysaccharide pneumococcal vaccine a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veras, Maria Amelia SM, Enanoria, Wayne TA, Castilho, Euclides A, Reingold, Arthur L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2148048/ https://www.ncbi.nlm.nih.gov/pubmed/17956620 http://dx.doi.org/10.1186/1471-2334-7-119

Ejemplares similares

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals
por: Leggat, David J, et al.
Publicado: (2015)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020)

The effect of age on the response to the pneumococcal polysaccharide vaccine
por: Lee, Hyunju, et al.
Publicado: (2010)

Pneumococcal vaccination of older adults: Conjugate or polysaccharide?
por: Hollingsworth, Rosalind, et al.
Publicado: (2014)

Pneumococcal Polysaccharide Vaccine Ameliorates Murine Lupus
por: Cantarelli, Chiara, et al.
Publicado: (2019)

Polysaccharide Responsiveness Is Not Biased by Prior Pneumococcal-Conjugate Vaccination
por: Bernth-Jensen, Jens Magnus, et al.
Publicado: (2013)

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
por: Rijkers, Ger T, et al.
Publicado: (2018)

Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease
por: Temtem, Tsega, et al.
Publicado: (2019)

A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis
por: Tin Tin Htar , Myint, et al.
Publicado: (2013)

A call for a more comprehensive SARS-CoV-2 sequence database for Brazil
por: Abbud, Adriano, et al.
Publicado: (2021)

642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients
por: Nicholson, Lindsay K, et al.
Publicado: (2018)

Late Entry into HIV Care: Estimated Impact on AIDS Mortality Rates in Brazil, 2003–2006
por: Grangeiro, Alexandre, et al.
Publicado: (2011)

Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
por: Belmonti, Simone, et al.
Publicado: (2019)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

70. Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018
por: Matanock, Almea, et al.
Publicado: (2021)

HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics
por: Galvão-Castro, Bernardo, et al.
Publicado: (2021)

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
por: Moore, R Andrew, et al.
Publicado: (2000)

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
por: Kuo, Chia-Sheng, et al.
Publicado: (2016)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2017)

Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy
por: Iyer, Anita S, et al.
Publicado: (2015)

Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children
por: Orami, Tilda, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil
por: de Soárez, Patrícia Coelho, et al.
Publicado: (2015)

647 Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States
por: Kim, Lindsay, et al.
Publicado: (2014)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
por: Bhorat, As’ad E., et al.
Publicado: (2015)

Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil
por: Andrade, Ana Lucia, et al.
Publicado: (2014)

Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.
por: Fiore, A E, et al.
Publicado: (1999)

Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
por: Satomura, Kazunari, et al.
Publicado: (2014)

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
por: Mori, Shunsuke, et al.
Publicado: (2013)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

1730. Increasing Vaccination Rates of 23-valent Pneumococcal Polysaccharide Vaccine Among Patients at High-Risk for Invasive Pneumococcal Disease
por: Lyon, Edward, et al.
Publicado: (2023)

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
por: Wilck, Marissa, et al.
Publicado: (2023)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
por: Shimbashi, Reiko, et al.
Publicado: (2020)

Global Control of Pneumococcal Infections by Pneumococcal Vaccines
por: Oishi, Kazunori, et al.
Publicado: (2014)

The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults
por: Feldman, Charles, et al.
Publicado: (2020)

Complementary Role of CD4+ T Cells in Response to Pneumococcal Polysaccharide Vaccines in Humans
por: Jha, Vibha, et al.
Publicado: (2019)

Multivalent pneumococcal vaccine and its preparation from polysaccharide purified from Pneumococcus
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_i9qebdms191qibti39ncc2tqv7